Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 10
Submit an article Journal homepage
5,569
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Matching-adjusted indirect comparisons of safety and efficacy of acalabrutinib versus other targeted therapies in patients with treatment-naïve chronic lymphocytic leukemia

Matthew S. Davidsa Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USAView further author information
,
Claire Telfordb AstraZeneca, Gaithersburg, MD, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6983-4028View further author information
ORCID Icon,
Sarang Abhyankarb AstraZeneca, Gaithersburg, MD, USAView further author information
,
Catherine Wawerub AstraZeneca, Gaithersburg, MD, USAView further author information
&
Ingo Ringshausenc Department of Haematology, University of Cambridge, Cambridge, UKView further author information
Pages 2342-2351 | Received 28 Sep 2020, Accepted 29 Mar 2021, Published online: 06 May 2021

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.